Table 1 Baseline characteristics of participants

Participants, n

33,964

8491

—

Age, years

62.57 ± 10.11

62.58 ± 10.11

1.000

Male,n(%)

30,436(89.61)

7609(89.61)

1.000

Current smoking, n(%)

12,702(37.40)

3482(41.01)

<0.001

Current drinking, n(%)

11,035(32.49)

2624(30.90)

0.005

High salty diet, n(%)

3012(8.87)

894(10.53)

0.048

BMI(≥ 28 kg/m²), n(%)

5430(15.99)

1794(21.03)

<0.001

Physical activity, n(%)

5572(16.41)

1318(15.52)

0.092

Manual labor, n(%)

30,310(89.24)

7818(92.07)

<0.001

High-income level, n(%)

3539(10.42)

832(9.80)

<0.001

≥Senior high school, n(%)

5194(15.29)

1032(12.15)

<0.001

TC mmol/L

4.99 ± 1.16

5.08 ± 1.32

<0.001

TG mmol/L M(P₂₅,P₇₅)

1.26(0.89,1.89)

1.38(0.98,2.12)

<0.001

HDL_C mmol/L

1.48 ± 0.44

1.45 ± 0.44

<0.001

LDL_C mmol/L

2.66 ± 0.90

2.73 ± 0.93

<0.001

FBG mmol/L

5.80 ± 1.71

6.38 ± 2.49

<0.001

hs-CRP,mg/L(P25,P75)

1.20(0.50,2.97)

1.40(0.60,3.43)

<0.001

Hypertension, n(%)

18,712(55.09)

6532(76.93)

<0.001

Diabetes, n(%)

4958(14.60)

2084(24.54)

<0.001

History of myocardial infarction, n(%)

700(2.06)

225(2.65)

<0.001

History of atrial fibrillation, n(%)

740(2.18)

317(3.73)

<0.001

History of malignant tumor, n(%)

405(1.19)

94(1.11)

0.514

Antidiabetic treatment, n(%)

2194(6.46)

894(10.53)

<0.001

Lipid-lowering treatment, n(%)

3063(9.02)

1779(20.95)

<0.001

Antihypertensive treatment, n(%)

10,958(32.26)

4515(53.17)

<0.001